Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2026)

Camp4 Therapeutics has reported Total Current Liabilities for 4 years, with the latest figure at $16.6 million in Q1 2026.

• Quarterly Total Current Liabilities rose 158.1% year-over-year to $16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 158.1% YoY) and the FY2025 annual result came in at $15.5 million, up 61.64% from the prior year.
• Total Current Liabilities rose to $16.6 million in Q1 2026 per CAMP's latest filing, from $15.5 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $16.6 million in Q1 2026 and troughed at $6.4 million in Q1 2025.
• A 4-year average of $10.4 million and a median of $8.8 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities plunged 33.19% in 2025, then surged 158.1% in 2026.
• Over 4 years, Total Current Liabilities stood at $7.8 million in 2023, then advanced by 22.94% to $9.6 million in 2024, then jumped by 61.64% to $15.5 million in 2025, then advanced by 7.15% to $16.6 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $16.6 million, $15.5 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.